Clinical Trial Update: Factors Influencing Hepatitis B Virus Reactivation in Lymphoma Patients Treated With Rituximab

View source ↗

Summary

This completed trial evaluated factors associated with hepatitis B reactivation in patients with diffuse large B-cell lymphoma or follicular lymphoma treated wi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma
• Follicular Lymphoma

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Doxorubicin (doxorubicin)
• PREDNISONE (Prednisone)
• Rituximab (rituximab)
• Vincristine (vincristine)

Snippet

Sponsor: Samsung Medical Center | Conditions: Patients With Diffuse Large B-cell Lymphoma or Follicular Lymphoma, Patients Treated With Rituximab-CHOP or Rituximab-CVP | Status: COMPLETED